FACTANKER

Altamira Therapeutics Ltd.: xbrl:AdjustmentsForDepreciationExpense

Value{"unit": "CHF", "value": 59444}
Period2022-01-01 – 2022-06-30
Statuscurrent
EntityAltamira Therapeutics Ltd.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001213900-22-076042
Retrieved: 2026-08-19T16:24:25.793555+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Cite as: FACTANKER, https://factanker.com/fact/7332db65-5ffa-4dc7-9f01-a8ef5d51b1a7

History